Liquidia Corporation (LQDA) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Morrisville, NC, United States. The current CEO is Roger A. Jeffs.
LQDA has IPO date of 2018-07-26, 170 full-time employees, listed on the NASDAQ Capital Marke, a market capitalization of $3.41B.
Liquidia Corporation is a biopharmaceutical company founded in 2004 and headquartered in Morrisville, North Carolina, focused on developing and commercializing innovative treatments for unmet patient needs in the United States. The company's lead product candidate, YUTREPIA, is an inhaled dry powder formulation of treprostinil designed to treat pulmonary arterial hypertension. In addition to its proprietary pipeline, Liquidia manufactures and distributes generic treprostinil injection throughout the U.S. market, combining both innovative drug development and generic pharmaceutical distribution capabilities.
